Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Goldsmith

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Psychiatry Research|August 28, 2024
Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosisSimon Cohen, David R Goldsmith, Courtney S Ning, et al.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Psychiatry Research|August 28, 2024
Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosisSimon Cohen, David R Goldsmith, Courtney S Ning, et al.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology|April 8, 2025
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I: A Review of the Pharmacokinetic Literature and Proposed ChangesJose de Leon, Ross J Baldessarini, Richard Balon, et al.
Pageof 8